Introduction: The aim of this work was to characterize a new strain of (CNCM I-4866) (CNCM I-4866) to address its potential as probiotic with a special focus on intestinal inflammation. Potential anti-inflammatory abilities of this strain were evaluated through and experiments.
Methods: Firstly, the strain was tested in a murine acute inflammation colitis model induced by DNBS.